Longitudinal analysis of the prevalence and correlates of heavy episodic drinking and self-reported opioid use among a national cohort of patients with HIV.
alcohol-related disorders
cohort studies
drug overdose
human immunodeficiency virus
opioid-related disorders
Journal
Alcoholism, clinical and experimental research
ISSN: 1530-0277
Titre abrégé: Alcohol Clin Exp Res
Pays: England
ID NLM: 7707242
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
revised:
20
02
2022
received:
16
08
2021
accepted:
25
02
2022
pubmed:
9
3
2022
medline:
20
4
2022
entrez:
8
3
2022
Statut:
ppublish
Résumé
Heavy episodic drinking (HED) is a risk factor for opioid-related overdose and negatively impacts HIV disease progression. Among a national cohort of patients with HIV (PWH), we examined sociodemographic and clinical correlates of concomitant HED and self-reported opioid use. We used data collected from 2002 through 2018 from the Veterans Aging Cohort Study, a prospective cohort including PWH in care at eight US Veterans Health Administration sites. HED was defined as consuming six or more drinks at least once in the year prior to survey collection. We examined the relationship between HED and self-reported opioid use and created a 4-level composite variable of HED and opioid use. We used multinomial logistic regression to estimate odds of reporting concomitant HED and self-reported opioid use. Among 3702 PWH, 1458 (39.4%) reported HED during the study period and 350 (9.5%) reported opioid use. In the multinomial model, compared to reporting neither HED nor opioid use, lifetime housing instability (adjusted odds ratio [aOR] 1.54, 95% confidence interval [CI] 1.01 to 2.35), Veterans Aging Cohort Study Index 2.0 (a measure of disease severity; aOR 1.14, 95% CI 1.02 to 1.28), depressive symptoms (aOR 2.27, 95% CI 1.42 to 3.62), past-year cigarette smoking (aOR 3.06, 95% CI 1.53 to 6.14), cannabis use (aOR 1.69, 95% CI 1.09 to 2.62), and cocaine/stimulant use (aOR 11.54, 95% CI 7.40 to 17.99) were independently associated with greater odds of concomitant HED and self-reported opioid use. Compared to having attended no college, having some college or more (aOR 0.39, 95% CI 0.26 to 0.59) was associated with lower odds of concomitant HED and self-reported opioid use. Among PWH, concomitant HED and self-reported opioid use are more common among individuals with depressive symptoms and substance use, structural vulnerabilities, and greater illness severity. Efforts to minimize opioid-related risk should address high-risk drinking as a modifiable risk factor for harm among these groups.
Sections du résumé
BACKGROUND
Heavy episodic drinking (HED) is a risk factor for opioid-related overdose and negatively impacts HIV disease progression. Among a national cohort of patients with HIV (PWH), we examined sociodemographic and clinical correlates of concomitant HED and self-reported opioid use.
METHODS
We used data collected from 2002 through 2018 from the Veterans Aging Cohort Study, a prospective cohort including PWH in care at eight US Veterans Health Administration sites. HED was defined as consuming six or more drinks at least once in the year prior to survey collection. We examined the relationship between HED and self-reported opioid use and created a 4-level composite variable of HED and opioid use. We used multinomial logistic regression to estimate odds of reporting concomitant HED and self-reported opioid use.
RESULTS
Among 3702 PWH, 1458 (39.4%) reported HED during the study period and 350 (9.5%) reported opioid use. In the multinomial model, compared to reporting neither HED nor opioid use, lifetime housing instability (adjusted odds ratio [aOR] 1.54, 95% confidence interval [CI] 1.01 to 2.35), Veterans Aging Cohort Study Index 2.0 (a measure of disease severity; aOR 1.14, 95% CI 1.02 to 1.28), depressive symptoms (aOR 2.27, 95% CI 1.42 to 3.62), past-year cigarette smoking (aOR 3.06, 95% CI 1.53 to 6.14), cannabis use (aOR 1.69, 95% CI 1.09 to 2.62), and cocaine/stimulant use (aOR 11.54, 95% CI 7.40 to 17.99) were independently associated with greater odds of concomitant HED and self-reported opioid use. Compared to having attended no college, having some college or more (aOR 0.39, 95% CI 0.26 to 0.59) was associated with lower odds of concomitant HED and self-reported opioid use.
CONCLUSIONS
Among PWH, concomitant HED and self-reported opioid use are more common among individuals with depressive symptoms and substance use, structural vulnerabilities, and greater illness severity. Efforts to minimize opioid-related risk should address high-risk drinking as a modifiable risk factor for harm among these groups.
Identifiants
pubmed: 35257397
doi: 10.1111/acer.14801
pmc: PMC9018502
mid: NIHMS1786448
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
600-613Subventions
Organisme : NIAAA NIH HHS
ID : P01 AA029545
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA040471
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA020790
Pays : United States
Informations de copyright
© 2022 by the Research Society on Alcoholism.
Références
AIDS Care. 2021 Feb 4;:1-8
pubmed: 33535800
Med Care. 2006 Aug;44(8 Suppl 2):S13-24
pubmed: 16849964
AIDS. 2012 Feb 20;26(4):403-17
pubmed: 22112599
Drug Alcohol Depend. 2016 Apr 1;161:59-66
pubmed: 26857898
Am J Public Health. 2008 Feb;98(2):216-21
pubmed: 18172133
Postgrad Med. 2013 Jul;125(4):115-30
pubmed: 23933900
Natl Vital Stat Rep. 2018 Jul;67(5):1-76
pubmed: 30248015
Biometrics. 1986 Mar;42(1):121-30
pubmed: 3719049
J Acquir Immune Defic Syndr. 2019 Aug 1;81(4):448-455
pubmed: 30973541
MMWR Morb Mortal Wkly Rep. 2018 Mar 30;67(12):349-358
pubmed: 29596405
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
Alcohol Clin Exp Res. 2006 Jun;30(6):922-7
pubmed: 16737449
AIDS. 2019 Apr 1;33(5):903-912
pubmed: 30649058
Drug Alcohol Depend. 2018 Jun 1;187:48-54
pubmed: 29627405
JAMA Netw Open. 2020 Apr 1;3(4):e202361
pubmed: 32271389
Drug Alcohol Depend. 2010 Jan 15;106(2-3):119-25
pubmed: 19758770
Drug Alcohol Depend. 2016 Apr 1;161:95-103
pubmed: 26861883
J Subst Abuse Treat. 2020 Feb;109:14-22
pubmed: 31856946
AIDS Behav. 2017 Jul;21(7):1914-1925
pubmed: 28285434
Alcohol Clin Exp Res. 2016 Oct;40(10):2056-2072
pubmed: 27696523
J Acquir Immune Defic Syndr. 2020 May 1;84(1):26-36
pubmed: 32267658
AIDS Behav. 2019 Jan;23(1):140-151
pubmed: 29995206
Am J Prev Med. 2019 Aug;57(2):197-208
pubmed: 31200998
J Subst Abuse Treat. 2021 Dec;131:108546
pubmed: 34391586
Am J Public Health. 2005 Jul;95(7):1149-55
pubmed: 15983270
AIDS. 2017 Jun 1;31(9):1313-1321
pubmed: 28492393
J Acquir Immune Defic Syndr. 2021 Jul 1;87(3):959-970
pubmed: 33675619
J Gen Intern Med. 2013 Jan;28(1):82-90
pubmed: 22895747
Alcohol Clin Exp Res. 2011 Dec;35(12):2101-12
pubmed: 21919918
J Clin Epidemiol. 2001 Dec;54 Suppl 1:S77-90
pubmed: 11750213
J Addict Med. 2021 Jan-Feb 01;15(1):3-7
pubmed: 32482955
Alcohol Clin Exp Res. 2013 Mar;37(3):435-42
pubmed: 23050632
Clin Infect Dis. 2005 Oct 1;41(7):1027-34
pubmed: 16142670
Drug Alcohol Depend. 2017 Sep 1;178:501-511
pubmed: 28719884
Pharmacotherapy. 2018 Apr;38(4):436-443
pubmed: 29484686
NCHS Data Brief. 2020 Dec;(394):1-8
pubmed: 33395384
Pain Pract. 2014 Mar;14(3):207-16
pubmed: 23551857
AIDS Behav. 2016 Mar;20(3):679-86
pubmed: 26384973
N Engl J Med. 2019 Jun 6;380(23):2246-2255
pubmed: 31167053
Alcohol Clin Exp Res. 2018 Mar;42(3):478-488
pubmed: 29314075
N Engl J Med. 2005 Feb 10;352(6):596-607
pubmed: 15703424
Arch Intern Med. 2003 Apr 14;163(7):821-9
pubmed: 12695273
Curr Opin Psychiatry. 2014 Jul;27(4):269-75
pubmed: 24852056
Am J Mens Health. 2019 May-Jun;13(3):1557988319859113
pubmed: 31216926
MMWR Morb Mortal Wkly Rep. 2015 Jun 19;64(23):631-5
pubmed: 26086633
J Gen Intern Med. 2008 Jun;23(6):781-7
pubmed: 18421511
JAMA. 2018 Nov 13;320(18):1869-1871
pubmed: 30422181
AIDS Care. 2021 Jun 11;:1-11
pubmed: 34114904
Addiction. 2016 Jul;111(7):1160-74
pubmed: 27265421
AIDS Care. 2021 Aug;33(8):1024-1036
pubmed: 32808534
Drug Alcohol Depend. 2017 May 1;174:113-120
pubmed: 28324813
Alcohol Clin Exp Res. 2020 Sep;44(9):1807-1815
pubmed: 32628784
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
MMWR Morb Mortal Wkly Rep. 2020 Mar 13;69(10):265-270
pubmed: 32163383
JAMA. 2018 Nov 13;320(18):1899-1909
pubmed: 30422199
Drug Alcohol Depend. 2017 Oct 1;179:416-423
pubmed: 28867560
Public Health Rep. 2002;117 Suppl 1:S135-45
pubmed: 12435837
J Addict Med. 2010 Sep;4(3):123-30
pubmed: 20936079